Finland· FI-REL-REL12038
Zubrin
A muut tulehdus- ja reumalääkkeet product containing tepoxalin, registered in Finland by Intervet International B.V..
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Tepoxalin
- Manufacturer
- Intervet International B.V.
- Country
- Finland (FI)
- ATC code
- QM01AX
- ATC class
- Muut tulehdus- ja reumalääkkeet
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QM01AX
Muut tulehdus- ja reumalääkkeet, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a3c3eed-9f18-4c0e-8476-bb4b64fd1ed0 GET /v1/drugs/9a3c3eed-9f18-4c0e-8476-bb4b64fd1ed0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kylmäkuivattu",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "200 mg",
"atc_label": "Muut tulehdus- ja reumalääkkeet",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/2/00/28/06-08",
"fimea_rel_id": "REL12038",
"authorised_at": "2001-03-13"
}See everything about tepoxalin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.